Tag - Parkinson’s

Feature

Clene Nanomedicine developing first nanotherapeutic for neurodegenerative disease

Closely-held Clene Nanomedicine is developing catalytic drugs to treat neurodegenerative diseases, using its clean surface nanocrystal (CSN) therapeutics platform to increase cellular bioenergy. “We’re the first...

December 17, 2019

Developments

Dawson James starts Anavex at buy: PT $16

Dawson James initiated coverage of Anavex Life Sciences (NASDAQ:AVXL) with a “buy” rating and $16 price target. The stock closed $2.54 on July 23. Anavex is pioneering a new treatment in CNS diseases like...

July 24, 2019

Developments

Intec Parkinson’s disease candidate misses primary endpoint in Phase 3 trial

Intec Pharma (NASDAQ:NTEC) reported that its Accordion Pill carbidopa/levodopa (AP-CD/LD) failed to meet its primary endpoint in a Phase 3 trial for Parkinson’s disease (PD). Intec’s extended release AP-CD/LD failed to...

July 22, 2019

Tag - Parkinson’s

Clene Nanomedicine developing first nanotherapeutic for neurodegenerative disease

Dawson James starts Anavex at buy: PT $16

Intec Parkinson’s disease candidate misses primary endpoint in Phase 3 trial

General

More